In pancreatic cancer, the crucial role of CD44/TGFβ receptors (TβRI and TβRII) signalling is well admitted not only in epithelial-to-mesenchymal transition but also in the earlier ADM step. The gene discussed is TGFBR2; the disease is pancreatic neoplasm.